On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Medtronic's MiniMed 670G - the closest thing ... the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to self-inject basal insulin ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Consumers saw price relief at the gas pump and grocery store. But housing inflation and other categories, such as car ...

"Rising Chronic Disease Cases and Advancements in Medical Technology Drive Rapid Growth in the Infusion Pump Market" BOSTON, ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...